|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Xechem International (XKEM) Among Finalist As Prestigious Innovated Company for NJBIZ HealthCare Heroes Award
6/4/2007 1:32:03 PM
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Dr. Ramesh C. Pandey, Chairman of the Board and Chief Executive Officer of Xechem International, Inc. (OTC BB: XKEM), announced that Xechem is among the finalist for the NJBIZ Healthcare Company Innovation Hero Award. The winner will be announced at the awards ceremony, sponsored by Amerihealth, Children’s Specialized Hospitals, Wolf Block and Verizon Wireless, on June 11th at 8:00am at the Woodbridge Sheraton in Woodbridge, New Jersey.
“I am thrilled to see that Xechem International is among the finalist for this prestigious healthcare industry honor organized by NJBIZ,” said H. Scott English, Director of Investor Relations for Xechem. “Dr. Ramesh Pandey and the Xechem team have proven their talents with work they have done on NICOSAN™/HEMOXIN™. The commitment of Dr. Pandey to establish Xechem Pharmaceuticals Nigeria Ltd. is applauded, in bringing the first herbal drug from the African continent for a disease where a non-toxic drug did not exist in the global market to help the life survival of millions of Sickle Cell Anemia sufferers in Nigeria and around the world.”
|
|
|
|
|
|
|
|
|
|
|